EnForeSys® enrollment forecasting showcases at SCOPE

Posted by Cytel

Feb 17, 2016 12:32:45 PM

Charles Liu, Statistician and Product Manager at Cytel will be part of the expert speaker panel at the 7th Annual SCOPE Summit on 23-26th February. This year’s meeting is taking place in Miami, and offers a packed program with tracks covering such varied topics as risk based monitoring, clinical data technology and integration, and managing outsourced clinical trials. SCOPE has become one of the...

Read More

Topics: feasibility studies, patient enrollment, enforesys, Scope conference


3 Questions to Ask About Your Trial's Enrollment

Posted by Charles Liu

Jul 2, 2015 1:33:01 PM

 

Clyde Haberman, a columnist for the New York Times, once commented on the remarkable consistency of train arrival times on the Tokyo subway: "Every station lists the scheduled arrival times: 9:01, 9:04, 9:08 and so on. I lived in that city for five years...I never saw a train arrive so much as a minute late, not once. A posting of 9:01 meant 9:01." [1]. Such predictability is rarely observed in...

Read More

Topics: feasibility studies, patient enrollment, enforesys


Patient Recruitment Feasibility: Would you bet $12 million dollars on it?

Posted by Charles Liu

Jun 4, 2015 3:11:26 PM

Two insightful papers from Applied Clinical Trials should be of interest to many clinical trial planners. The first by Kenneth Getz describes the problem of enrollment performance, while the second by Matthew Kibby proposes a potential solution. The Facts

Getz reports a study providing recent estimates of industry-wide rates of enrollment delays [1]. In 2012, the Tufts Center for the Study...

Read More

Topics: feasibility studies, patient enrollment, enforesys


Data-Driven Trial Planning: An Interview with Pfizer's Chris Conklin

Posted by Cytel

Feb 12, 2015 2:59:00 PM

Data driven decision-making can ensure that every feasibility team achieves its enrollment milestones. By transforming how pharmaceutical companies and CROs conduct feasibility studies, new techniques in recruitment planning are affecting every aspect of trial planning and clinical development strategy.

We sat down with Chris Conklin, the Director of the Feasibility Center for Excellence at...

Read More

Topics: Clinical Development Strategy, feasibility studies, patient enrollment


3 Key Trends in Clinical Trial Enrollment Forecasting

Posted by Esha Senchaudhuri

Feb 5, 2015 4:50:00 PM

Every clinical trial requires some manner of trial forecasting, normally for feasibility and patient enrollment. However, studies reveal that more than 50% of clinical trials fail to meet enrollment targets, and that enrollment is the most commonly cited reason for Phase 3 trial discontinuation [1].

Read More

Topics: feasibility studies, patient enrollment


How to Take Control of Your Enrollment Woes

Posted by Esha Senchaudhuri

Jan 27, 2015 4:01:00 PM

Last week we released an infographic on why Phase 3 trials fail. The numbers, while eye-opening, did not capture a related and equally important issue: Why are so many late stage clinical trials discontinued?

Nearly 50% of all Phase 3 trials that are submitted to the FDA fail upon first submission [1]. However, 25% of all trials that begin are never even submitted for review [2].  According to a...

Read More

Topics: feasibility studies, patient enrollment, trial planning


The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.  Sign up for updates direct to your inbox. You can unsubscribe at any time.

 

Posts by Topic

see all

Recent Posts